相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。PRAME expression in 155 cases of metastatic melanoma
Sarah E. Gradecki et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
PRAME immunohistochemistry as an adjunct for diagnosis and histological margin assessment in lentigo maligna
Sarah E. Gradecki et al.
HISTOPATHOLOGY (2021)
The utility of PRAME staining in identifying malignant transformation of melanocytic nevi
Mary E. Lohman et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2021)
The Rapid Rise in Cutaneous Melanoma Diagnoses
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Immunohistochemistry for PRAME in the Distinction of Nodal Nevi From Metastatic Melanoma
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
Differential Expression of Cancer Testis Antigens on Lentigo Maligna and Lentigo Maligna Melanoma
Darryl Tio et al.
AMERICAN JOURNAL OF DERMATOPATHOLOGY (2020)
Comparison of Immunohistochemistry for PRAME With Cytogenetic Test Results in the Evaluation of Challenging Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2020)
PRAMEexpression in melanocytic proliferations with intermediate histopathologic or spitzoid features
Shyam S. Raghavan et al.
JOURNAL OF CUTANEOUS PATHOLOGY (2020)
PRAME Expression in Melanocytic Tumors
Cecilia Lezcano et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2018)
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
Joann G. Elmore et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Pathologists' diagnosis of invasive melanoma and melanocytic proliferations: observer accuracy and reproducibility study
Joann G. Elmore et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Tumor antigen PRAME is up-regulated by MZF1 in cooperation with DNA hypomethylation in melanoma cells
Yong-Kyu Lee et al.
CANCER LETTERS (2017)
Melanoma Thickness and Survival Trends in the United States, 1989-2009
Waqas R. Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
Melanoma Thickness and Survival Trends in the United States, 1989-2009
Waqas R. Shaikh et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2016)
PRAME as an Independent Biomarker for Metastasis in Uveal Melanoma
Matthew G. Field et al.
CLINICAL CANCER RESEARCH (2016)
More People Die from Thin Melanomas (≤1 mm) than from Thick Melanomas (>4 mm) in Queensland, Australia
David C. Whiteman et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2015)
Prognostic significance of PRAME expression based on immunohistochemistry for diffuse large B-cell lymphoma patients treated with R-CHOP therapy
Kenjiro Mitsuhashi et al.
INTERNATIONAL JOURNAL OF HEMATOLOGY (2014)
DNA Methylation Characteristics of Primary Melanomas with Distinct Biological Behaviour
Szilvia Ecsedi et al.
PLOS ONE (2014)
Increased diagnosis of thin superficial spreading melanomas: A 20-year study
Jason E. Frangos et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2012)
Melanoma Thickness Trends in the United States, 1988-2006
Vincent D. Criscione et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2010)
PRAME expression and clinical outcome of breast cancer
M. T. Epping et al.
BRITISH JOURNAL OF CANCER (2008)
A functional genetic screen identifies retinoic acid signaling as a target of histone deacetylase inhibitors
Mirjam T. Epping et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Expression of cancer testis antigens in head and neck squamous cell carcinomas
David L. A. Figueiredo et al.
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2006)
Skin biopsy rates and incidence of melanoma: population based ecological study
HG Welch et al.
BRITISH MEDICAL JOURNAL (2005)
The approach to the patient with a difficult melanocytic lesion
DE Elder et al.
PATHOLOGY (2004)
Intratumor heterogeneity of cancer/testis antigens expression in human cutaneous melanoma is methylation-regulated and functionally reverted by 5-aza-2′-deoxycytidine
L Sigalotti et al.
CANCER RESEARCH (2004)
The tumor-associated antigen PRAME is universally expressed in high-stage neuroblastoma and associated with poor outcome
A Oberthuer et al.
CLINICAL CANCER RESEARCH (2004)
Grading of atypia in nevi: Correlation with melanoma risk
M Arumi-Uria et al.
MODERN PATHOLOGY (2003)
Cancer/testis antigens: an expanding family of targets for cancer immunotherapy
MJ Scanlan et al.
IMMUNOLOGICAL REVIEWS (2002)
分享论文
